CytoMed Therapeutics (GDTC) Total Current Liabilities (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Total Current Liabilities of $547179.2 for Q4 2025, down 22.18% sequentially from $703092.0 in Q2 2025, and up 19.98% YoY from $456044.1 in Q4 2024.
CytoMed Therapeutics (GDTC) Total Current Liabilities (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Total Current Liabilities for 5 years, with the latest figure at $547179.2 in Q4 2025.
- Quarterly Total Current Liabilities rose 19.98% year-over-year to $547179.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $547179.2 (up 19.98% YoY) and the FY2025 annual result came in at $551496.0, up 21.44% from the prior year.
- Total Current Liabilities fell to $547179.2 in Q4 2025 per GDTC's latest filing, from $703092.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $3.0 million in Q4 2022 and troughed at $314878.0 in Q2 2023.
- A 5-year average of $1.0 million and a median of $539106.7 in 2025 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities slumped 82.31% in 2023, then surged 96.44% in 2025.
- Over 5 years, Total Current Liabilities stood at $2.2 million in 2021, then jumped by 38.7% to $3.0 million in 2022, then plunged by 82.31% to $531034.3 in 2023, then declined by 14.12% to $456044.1 in 2024, then climbed by 19.98% to $547179.2 in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $547179.2, $703092.0, and $456044.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 630.93 Mn |
| 10 | CytoMed Therapeutics | 9.97 Mn | 8.35 Mn | - | 547,179.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 547,179.18 |
| Jun 30, 2025 | 703,092.00 |
| Dec 31, 2024 | 456,044.13 |
| Jun 30, 2024 | 357,919.00 |
| Dec 31, 2023 | 531,034.27 |
| Jun 30, 2023 | 314,878.00 |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 2.16 Mn |